Trends in the treatment and outcome of pancreatic cancer in the United States

Annals of Surgical Oncology

Volumn 14, Issue 4, 2007, Pages 1320-1326

  Baxter, Nancy N ^a   Whitson, Bryan A ^b   Tuttle, Todd M ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Pancreatic cancer; Population; Treatment; Trends

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; POPULATION RESEARCH; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PANCREATIC NEOPLASMS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 34047235205     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9249-8     Document Type: Article

References (16)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49:8-31.
2. O'Connell JB, Maggard MA, Ko CY. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol 2004; 11:962-9.
3. Castellanos J, Manifacio G, Lillehei RC, Shatney CH. Total pancreatectomy for ductal carcinoma of the head of the pancreas: current status. Am J Surg 1976; 131:595-8.
4. Crile G Jr. The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970; 130:1049-53.
5. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987; 206:358-65.
6. Janes RH, Jr., Niederhuber JE, Chmiel JS, et al. National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg 1996; 223:261-72.
7. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999; 89:1-7.
8. Surveillance, Epidemiology, and End Results (SEER). About SEER. National Cancer Institute. Available at: http://www.seer.cancer.gov/about/.
9. Linder S, Bostrom L, Nilsson B. Pancreatic cancer in Sweden 1980-2000: a population-based study of hospitalized patients concerning time trends in curative surgery and other interventional therapies. J Gastrointest Surg 2006; 10:672-8.
10. Rios G, Conrad A, Cole D, Adams D, Leveen M, O'Brien P, Baron P. Trends in indications and outcomes in the Whipple procedure over a 40-year period. Am Surg 1999; 65:889-93.
11. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996; 223:273-9.
12. Christein JD, Kendrick ML, Iqbal CW, Nagorney DM, Farnell MB. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J Gastrointest Surg 2005; 9:922-7.
13. Magistrelli P, Antinori A, Crucitti A, et al. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 2000; 74:36-40.
14. Krysa J, Miller M, Kukreja N, Steger A. Pancreatic cancer-is an aggressive approach justified?. Ann R Coll Surg Engl 2005; 87:163-6.
15. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995; 76:1671-7.
16. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2003; 85(5):476-80.